Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Andrew T. Frisch"'
Autor:
Benjamin Boyerinas, Greg M Delgoffe, Yupeng Wang, Alok Kumar, Ashley V Menk, Konstantinos Lontos, Yiyang Wang, Jason Lohmueller, Supriya K Joshi, Andrew T Frisch, McLane J Watson, Rachel Cumberland, Esteban Carrizosa
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background Cellular immunotherapies for cancer represent a means by which a patient’s immune system can be augmented with high numbers of tumor-specific T cells. Chimeric antigen receptor (CAR) therapy involves genetic engineering to ‘redirect’
Externí odkaz:
https://doaj.org/article/fd472df9a6d743fab850b3a2c42e8947
Autor:
B. Rhodes Ford, Paolo D. A. Vignali, Natalie L. Rittenhouse, Nicole E. Scharping, Ronal Peralta, Konstantinos Lontos, Andrew T. Frisch, Greg M. Delgoffe, Amanda C. Poholek
Publikováno v:
Sci Immunol
Response rates to immunotherapy in solid tumors remain low due in part to the elevated prevalence of terminally exhausted T cells, a hypofunctional differentiation state induced through persistent antigen and stress signaling. However, the mechanisms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b08924bb4f05a2d0d80de6a93062a38
https://europepmc.org/articles/PMC9851604/
https://europepmc.org/articles/PMC9851604/
Autor:
Konstantinos Lontos, Yiyang Wang, Supriya K Joshi, Andrew T Frisch, McLane J Watson, Alok Kumar, Ashley V Menk, Yupeng Wang, Rachel Cumberland, Jason Lohmueller, Esteban Carrizosa, Benjamin Boyerinas, Greg M Delgoffe
Publikováno v:
Journal for ImmunoTherapy of Cancer. 11:e006522
BackgroundCellular immunotherapies for cancer represent a means by which a patient’s immune system can be augmented with high numbers of tumor-specific T cells. Chimeric antigen receptor (CAR) therapy involves genetic engineering to ‘redirect’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6c4fa52df2e778263dac42e55d5d28e
https://doi.org/10.1136/jitc-2022-006522
https://doi.org/10.1136/jitc-2022-006522